Background: Cerebral spinal fluid eosinophilia (CSFe) is correlated with increased risk of cranial shunt malfunctions. Although antibiotics coated shunt catheters have significantly reduced the incidence of infections and associated shunt malfunction, on rare occasion they may contribute to a shunt allergy and become the source of subsequent malfunction.
Introduction
Shunt failure remains an ongoing problem in neurosurgery and is commonly associated with infection or mechanical obstruction. In certain cases of allergy or hypersensitivity reactions, the shunt system may become obstructed with inflammatory debris, ultimately leading to overt shunt malfunction [1] [2] [3] [4] . Clinical symptoms of shunt allergy or hypersensitivity reactions include abdominal pain, fever, recurrent skin breakdown along the shunt tract, abdominal distention, peritonitis, and non-specific complaints along the shun tract [2, 3, [5] [6] [7] . After detecting a shunt malfunction, it is important to perform a thorough workup in assessing for both infectious and noninfectious causes [1, 4, 5, [8] [9] [10] [11] [12] [13] .
Eosinophils are rarely seen within the cerebrospinal fluid, and when found they are usually associated with parasitic, bacterial or mycotic infections of the central nervous system [1, [12] [13] [14] [15] [16] . However, CSF eosinophilia may also be detected in up to 30% cases of allergic or aseptic shunt malfunctions [15] . We present the first described case of an arachnoid cyst treated with a cystoperitoneal shunt (CPF), which was subsequently complicated by sterile shunt malfunction secondary to CSFe and hypersensitivity reaction to Rifampin-Minocycline coated catheter, due to a previously undiagnosed Rifampin allergy.
Case Report
A 17 months-old-male with symptomatic arachnoid cyst underwent craniotomy for cyst fenestration of a large, compressive, temporal lobe, arachnoid cyst into the basilar cisterns, with temporary intracystic catheter placement, skin to that of an external ventricular drain. Patient went on to require further drainage via the intracystic catheter, for which he underwent a CPS placement. Immediately postoperatively he did well and was discharged home. In the neurologically stable, however, over the ensuing two months he developed an expanding pseudomeningocele at the cranial surgical site. The pseudomeningocele was intermittent in nature; on occasion it was minimally appreciated and at times it was noted to be bulging and tense. Shunt and pseudomeningocele taps were both negative for infectious etiology (including cell analysis, protein, glucose, gram stain, culture, and prolonged broth evaluation) on separate occasions. Both taps were revealing for elevated CSFe, which raised a concern of associated inflammatory reaction or concern of potentially indolent infection. Ultimately, he was admitted and further workup of CSF Intraoperatively, the patient's arachnoid cyst walls had thickened relative to his initial surgery and he had developed multiple adhesions within the cyst that were not previously present. After re-fenestration, an external inracystic catheter was placed in the cyst cavity and it was eventually weaned off as the fenestration site remained patent.
Discussion
Underlying CSF eosinophilia has been reported as both an incidental and benign finding in neurosurgical patinets [8, 9, 13, 14, [16] [17] [18] . However, when CSF eosinophilia is present, it may be an indicator of an underlying pathology associated with, or possible cause of shunt malfunction. In patients presenting with concern of shunt malfunction in the setting of elevated CSF eosinophil count, clinicians should consider workup of infection, benign underlying inflammatory reaction, or both [1, 2, 4, 6, 7, 9, 10, [12] [13] [14] 18] . CSF eosinophilia has been reported in association with infection such as parasitic, bacterial, or mycotic infection of the central nervous system [1, 7, 9, 12, 13, 15, 16, 19] . Additionally, CSF eosinophilia has also been reported in association with inflammatory reaction to antibiotic coated shunt catheters, as reported in the case of rifampin and minocycline impregnated shunt catheters [1-6, 8, 11, 14, 20, 21] . Minocycline has been more commonly reported culprit in cases of shunt malfunction. However
Rifampin has also been reported, as seen in this case report.
Patients, who present with signs of shunt malfunction with coexisting CSF eosinophilia, in the absence of shunt infection, should be considered for obstruction of the shunt system with inflammatory cell debris [2, 6, 7] . In the above case however, the arachnoid cyst contents, as well as a rifampin allergy could potentially contributed to high levels of CSF eosinophilia and secondary shunt failure [1, 22] . Spikes in eosinophilia were noted in the immediate 
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cyst fenestration, subsequent shunt placement, and repeat fenestration in this particular case report, as they have been previously discussed in the literature [16] . The inflammatory response likely contributed to the closure of initial fenestration, thickening of the cyst wall, and a granulomatous response, even prior to presenting with infection. Variations of eosinophilia in the CSF also correlated with congruent changes of CSF in the blood of these particular patients.
It is important to monitor patients with hypersensitivity reactions associated with sterile shunt malfunction as they are more likely to have multiple episodes of shunt failure [6, 9, 11, 17] . Treatment of aseptic shunt failure may include removal of the current shunt system and replacement with a hypoallergenic "extracted" shunt and in cases where CSF eosinophila has been determined, a course of steroids may ultimately reduce the inflammatory reaction and prolong shunt survival [14, 23] . This case demonstrates the importance of recognizing CSF eosinophilia and identifying other noninfectious causes of shunt failure in order to treat patients successfully and avoid future shunt complications.
Conclusion
In complex cases of shunted hyrocephalus, where a clear underlying cause is not determined, further workup to rule out infection, inflammatory changes, and hypersensitivity may be warranted. Recurrent presentations to the hospital after shunt hardware placement should prompt clinicians to conduct studies beyond routine CSF analysis and infectious process workup, as seen in this case. Elevated CSF eosinophil count, with or without elevated blood eosinophil count, could be a potential tool in the surgeon's armamentarium, when evaluating patients with such clinical concerns. Although, the specificity and sensitivity of CSFe is insufficient to use it as a screening tool, when interpreted in conjunction with clinical presentation, it can shine light on the underlying pathology of shunt failure [19] . This case also highlights the need for improved biocompatibility of shunt hardware to avoid conditions leading to shunt malfunction.
